All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
ICECURE MEDICAL LTD. Last Reported: 12/31/2023 Stock Symbol: ICCM

Business Address

7 HA'ESHEL ST., POB 3163

CAESAREA , IL 38900

Mailing Address

7 HA'ESHEL ST., POB 3163

CAESAREA , IL 38900
Phone Number: 972-4-6230333 / State Incorporated: / Fiscal Year End 12 /31

Balance Sheet

Date 12/31/2023 6/30/2023 12/31/2022 6/30/2022 12/31/2021 6/30/2021 12/31/2020 12/31/2019
Cash and Cash Equivalents $10,533,000.00 $3,031,000.00 $23,659,000.00 $13,468,000.00 $25,621,000.00 -- $3,502,000.00 --
Accounts Receivable Net Current $103,000.00 $118,000.00 $78,000.00 $184,000.00 $456,000.00 -- $94,000.00 --
Inventory $2,275,000.00 $2,751,000.00 $2,857,000.00 $2,651,000.00 $1,955,000.00 -- $1,064,000.00 --
Prepaid Expenses and Other Current Assets $744,000.00 -- -- -- -- -- -- --
Total Current Assets $14,184,000.00 $20,433,000.00 $28,130,000.00 $21,563,000.00 $30,322,000.00 -- $9,589,000.00 --
Property Plant and Equipement $1,513,000.00 $1,520,000.00 $1,356,000.00 $1,102,000.00 $713,000.00 -- $307,000.00 --
Intangible Assets Net -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- --
Other Assets -- -- -- -- -- -- -- --
Total Assets $16,410,000.00 $22,693,000.00 $30,188,000.00 $23,813,000.00 $32,281,000.00 -- $10,239,000.00 --
Accounts Payable $502,000.00 $652,000.00 $714,000.00 $937,000.00 $881,000.00 -- $645,000.00 --
Accrued Liabilities -- -- -- -- -- -- -- --
Total Current Liabilities -- $4,254,000.00 -- $4,937,000.00 -- -- -- --
Long Term Debt -- -- -- -- -- -- -- --
Additional Paid-in Capital -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss -- -- -- -- -- -- -- --
Accumulated Deficit $-90,061,000.00 $-83,066,000.00 $-75,409,000.00 $-67,399,000.00 $-58,431,000.00 -- $-48,536,000.00 --
Total Stockholders' Equity $12,163,000.00 $18,439,000.00 $25,422,000.00 $18,876,000.00 $26,958,000.00 $16,627,000.00 $5,648,000.00 $3,291,000.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- --
Total Liabilities and Equity $16,410,000.00 $22,693,000.00 $30,188,000.00 $23,813,000.00 $32,281,000.00 -- $10,239,000.00 --

Statement of Operations

Date 12/31/2023 6/30/2023 12/31/2022 6/30/2022 12/31/2021 6/30/2021 12/31/2020 12/31/2019
Total Revenues -- $1,647,000.00 $3,085,000.00 $1,512,000.00 $4,138,000.00 $2,073,000.00 $3,868,000.00 --
Cost of Revenues $1,929,000.00 $893,000.00 $1,640,000.00 $694,000.00 $1,943,000.00 $880,000.00 $1,424,000.00 --
Gross Profit $1,300,000.00 $754,000.00 $1,445,000.00 $818,000.00 $2,195,000.00 $1,193,000.00 $2,444,000.00 --
Research and Development $8,273,000.00 $4,190,000.00 $9,123,000.00 $4,649,000.00 $5,877,000.00 $2,730,000.00 $3,809,000.00 --
Selling, General, and Administrative -- -- $735,000.00 -- $177,000.00 -- $120,000.00 --
Total Operating Expenses -- -- -- -- -- -- -- --
Loss from Operations $-15,576,000.00 $-8,038,000.00 $-16,739,000.00 $-8,706,000.00 $9,724,000.00 $-3,746,000.00 $4,142,000.00 --
Loss Before Income Taxes -- -- -- -- -- -- -- --
Earnings Per Share Basic $0.32 $0.17 $0.46 $0.24 $0.35 $0.16 $0.22 --
Weighted Average Shares Basic 45,638,030 45,623,434 37,016,631 36,814,382 28,548,676 24,696,706 17,128,903 --
Earnings Per Share Diluted $0.32 $0.17 $0.46 $0.24 -- $0.16 -- --
Weighted Average Shares Diluted 45,638,030 45,623,434 37,016,631 36,814,382 -- 24,696,706 -- --
Common Stock Shares Authorized 2,500,000,000 2,500,000,000 2,500,000,000 2,500,000,000 2,500,000,000 -- 2,500,000,000 --
Common Stock Shares Outstanding 45,729,684 45,623,434 45,623,434 36,814,554 35,780,335 -- 20,218,220 --
Common Stock Value -- -- -- -- -- -- -- --
Common Stock Par Or Stated Value Per Share -- -- -- -- -- -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized -- -- -- -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share -- -- -- -- -- -- -- --
Share Price -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com